Skip to main content
. 2015 May 27;5:10575. doi: 10.1038/srep10575

Table 1. Correlations between LKB1 expression and clinicopathologic features in patients with pancreatic ductal adenocarcinoma (PDAC).

    Expression of LKB1  
Clinicopathological feature Total 205 Low (n = 36, 17.6%) High (n = 169, 82.4%) P value (χ2 test)
Age (years)
 ≤65 107 17 (15.9) 90 (84.1) 0.511
 >65 98 19 (19.4) 79 (80.6)  
Gender
 Male 117 16 (13.7) 101 (86.3) 0.092
 Female 88 20 (22.7) 68 (77.3)  
Clinical stage (AJCC)
 I 23 1 (4.3) 22 (95.7) 0.001
 II 135 19 (14.1) 116 (85.9)  
 III 34 14 (41.2) 20 (58.8)  
 IV 13 2 (15.4) 11 (84.6)  
Size
 ≤2 cm 41 3 (7.3) 38 (92.7) 0.054
 >2 cm 164 33 (20.1) 131 (79.9)  
T classification
 T1 7 0 (0.0) 7 (100.0) 0.025
 T2 31 1 (3.2) 30 (96.8)  
 T3 129 24 (18.6) 105 (81.4)  
 T4 38 11 (28.9) 27 (71.1)  
N classification
 Absent 143 19 (13.3) 124 (86.7) 0.015
 Present 62 17 (27.4) 45 (72.6)  
Liver metastasis
 Absent 192 30 (15.6) 162 (84.4) 0.005
 Present 13 6 (46.2) 7 (53.8)  
Vascular invasion
 Absent 178 26 (14.6) 152 (85.4) 0.004
 Present 27 10 (37.0) 17 (63.0)  
Tumor location
 Head 139 23 (16.5) 116 (83.5) 0.580
 Body/tail 66 13 (19.7) 53 (80.3)  
Histological differentiation
 Well 14 4 (28.6) 10 (71.4) 0.262
 Moderate/poor 191 32 (16.8) 159 (83.2)  

Values in parentheses indicate percentage values. The bold number represents the P-values with significant differences.